Lumidyne Technologies
Lumidyne Technologies–Commercialization of next-generation fluorescent probes with enhanced brightness and photostability across the visible spectrum. Lumidyne Technologies Team: Roger Altman Scott Blanchard
Read MoreJibon Health
We provide a low-cost and low-tech emergency obstetrics device for managing PPH in low resource settings. Jibon Health Team: Mikail Kamal Jason Rosenberg
Read MoreHistoWiz
HistoWiz is a histopathology service company that processes mouse tissue samples and digitalizes the result for cancer researchers in academia and pharma. Our mission is to fight for cancer cooperatively…
Read MoreSkinAxis
SkinAxis develops and provides an advanced 3D skin technologies for validation and discovery of drugs and cosmetic active ingredients in physiologically relevant conditions. SkinAxis Team: Arevik Mosoian Luca Gusella Elena…
Read MoreARL Designs
ARL Designs — Superhydrophobic Virtual-Well Microplates Enabling Accurate Nanoliter Dispensing for High Throughput/Content Screening at Low Cost. ARL Designs Team: Amy Lyons Xiaoxiao Chen Beth Kujan
Read MoreYiviva
Yiviva is a biotechnology company developing high-quality, evidence-based, botanical products to address aging-associated diseases. Yiviva Team: Peikwen Cheng Shwu-Huey Liu
Read MorePHD Biosciences
We are developing an enzyme inhibitor with pico-‐molar binding affinity and minimal toxicity as a once daily, oral therapeutic for the treatment of triple-‐negative breast cancer. Nanomedics LLC Team: Michael…
Read MoreOptologix
Optologix — Our product uses light to activate gene expression in cells and animals, allowing for nontoxic, rapid, precisely timed and localized induction unmatched by chemical-based methods. Optologix Team: Kevin…
Read MoreS.A.L.T
S.A.L.T is a point of care medical device that rapidly & reliably measures salt levels in urine using 2 urine strips and a mobile app. S.A.L.T Team: Fantasia Powell, Founder…
Read MoreNomoCan Pharmaceuticals
Utilizing a novel immunologic approach, NomoCan Pharmaceuticals is developing a targeted therapy for the treatment and prognosis of the most aggressive human cancer, pancreatic cancer. NomoCan Pharmaceuticals Team: Ehsan Sarafraz-Yazdi,…
Read More